Press release
Parkinson's Disease Market (U.S., EU5, Japan) to Reach USD 9.74 Billion by 2030
Parkinson's Disease Market
Introduction
The Parkinson's Disease (PD) Market in the 6/8 major markets is undergoing significant transformation as new drug classes, gene therapies, stem-cell-based interventions, and AI-assisted monitoring systems emerge. Parkinson's disease remains the second most common neurodegenerative condition, affecting millions across the U.S., Europe, and Japan.
As aging populations rise and healthcare systems expand access to advanced PD therapies, demand for next-generation therapeutics-including continuous levodopa delivery devices, dopamine agonists, MAO-B inhibitors, A2A antagonists, and innovative disease-modifying therapies-continues to accelerate.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73647
Key Takeaways
• Market Size (2023): USD 6.56 Billion
• Expected Market Size (2030): USD 9.74 Billion
• CAGR (2024-2030): 5.8%
• Growth driven by long-acting levodopa, infusion systems, and high-value neuroprotective therapies.
• Leading companies include AbbVie, Novartis, GSK, Teva Pharmaceuticals, UCB, Biogen, Amneal Pharmaceuticals, Acorda Therapeutics, Neurocrine Biosciences, and Merck.
• Sharp rise in clinical R&D for LRRK2 inhibitors, α-synuclein-targeted immunotherapies, gene therapies, and stem-cell-based regenerative treatments.
Market Story
The Parkinson's Disease treatment paradigm is undergoing a shift from decades of symptom-focused management to true disease-modifying therapy development.
1. Strong Growth in Long-Acting & Continuous Delivery Formulations
Newer solutions address "wearing-off" and motor fluctuations:
• Extended-release levodopa/carbidopa
• Subcutaneous infusion pumps
• Transdermal systems and inhaled formulations
These reduce "off" time and improve daily living performance.
2. Gene Therapy Innovation Accelerates
Companies are advancing:
• AAV-based gene therapies that stimulate dopamine production
• LRRK2 genetic pathway inhibitors
• GBA-targeted therapies for genetically linked PD forms
These therapies aim to slow or modify disease progression.
3. Stem Cell & Regenerative Therapies Gain Momentum
Clinical programs are exploring:
• Dopaminergic neuron transplants
• iPSC-based regenerative cell therapies
• Neurotrophic factor-mediated neural repair
Japan and the U.K. are leading early-stage approvals in regenerative neurology.
4. AI-Driven Remote Monitoring & Digital Neurology
Wearables and mobile platforms support:
• Tremor & gait analysis
• Medication response modeling
• Real-time symptom monitoring
• Tele-neurology management
These technologies enhance patient outcomes and reduce clinic burden.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73647/parkinson-s-disease-in-68-market
Market Segments
By Drug Class
• Levodopa/Carbidopa Combinations (dominant segment)
• Dopamine Agonists
• MAO-B Inhibitors
• COMT Inhibitors
• A2A Receptor Antagonists
• Anticholinergics
• VMAT2 Inhibitors
• Emerging Neuroprotective & Disease-Modifying Therapies
By Route of Administration
• Oral
• Injectable
• Transdermal
• Inhalation
• Implantable & Continuous Infusion Devices
By Patient Stage
• Early-Stage Parkinson's Disease
• Mid-Stage Parkinson's Disease
• Advanced Parkinson's Disease with Motor Complications
By Region (6/8 Markets)
• United States (largest share; >55% of total market value)
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
Recent Developments
• AbbVie advanced next-generation Duopa/Duodopa delivery systems for better motor control.
• UCB progressed its α-synuclein antibody into later-phase trials.
• Amneal launched enhanced extended-release levodopa products for longer on-time.
• Biogen expanded its neurodegenerative portfolio through acquisitions and partnerships.
• GSK invested in novel mitochondrial stabilization drug platforms.
• Teva strengthened its global distribution of PD symptomatic therapies.
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73647
Expert Quote
"Parkinson's disease care is entering a new era, marked by the rise of regenerative therapies, precision diagnostics, and long-acting drug delivery systems. These advancements are creating strong clinical and commercial momentum across major global markets."
-Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Market Drivers
• Rising prevalence across aging populations
• Progress in neuroprotective & disease-modifying pipelines
• Rapid adoption of infusion pumps, patches & digital neurology solutions
• Growing investment in gene therapy & regenerative medicine
• Improved reimbursement and access in U.S., EU5 & Japan
• Increased clinical trials for LRRK2, α-synuclein & A2A targets
Forecast Outlook
The market will exceed USD 9.74 billion by 2030, driven by:
• Launch of advanced neurotherapeutics
• Rising biologics and gene therapy approvals
• High adoption of long-acting levodopa products
• Expansion of specialty neurology centers
Regional Highlights
• U.S. dominates due to high therapy uptake and advanced neurology infrastructure.
• EU5 shows strong biosimilar and specialty-care growth.
• Japan leads Asia in regenerative neurology, driving faster adoption.
Government & Regulatory Initiatives
• FDA breakthrough designations for neuroprotective therapies
• EMA support for advanced therapy medicinal products (ATMPs)
• Japan PMDA leadership in stem-cell therapy approvals
• NIH & EU Horizon neuroscience funding
• National Parkinson's awareness & early diagnosis programs
Conclusion
The Parkinson's Disease Market across the 6/8 global markets is evolving quickly, driven by precision neurology, regenerative medicine, advanced drug-delivery platforms, and strong R&D pipelines. Companies focusing on disease-modifying therapies and next-generation formulations will lead the market through 2030.
This report is also available in the following languages : Japanese (68の市場におけるパーキンソン病), Korean (68년 시장의 파킨슨병), Chinese (68 市场中的帕金森病), French (Maladie de Parkinson sur 68 marchés), German (Parkinson-Krankheit im 68. Markt), and Italian (Malattia di Parkinson nel mercato 68), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73647
Our More Reports:
Aseptic Filling Machine Market
https://exactitudeconsultancy.com/reports/73535/aseptic-filling-machine-market
Non-Viral Transfection Reagents Market
https://exactitudeconsultancy.com/reports/73537/non-viral-transfection-reagents-market
Cell Sorting Market
https://exactitudeconsultancy.com/reports/73539/cell-sorting-market
Pharmaceutical Spray Drying Market
https://exactitudeconsultancy.com/reports/73539/cell-sorting-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinson's Disease Market (U.S., EU5, Japan) to Reach USD 9.74 Billion by 2030 here
News-ID: 4295202 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
